Nara Organics of New York, NY, is voluntarily recalling all lots of Nara Organics Powdered Infant Formula currently on the market out of an abundance of caution due to the potential risk of Clostridium botulinum contamination.
Infant botulism is a rare but potentially fatal illness that presents a serious threat to the health of infants which occurs when Clostridium botulinum spores are ingested and colonize the intestinal tract, producing botulinum neurotoxins in the immature gut of infants. Affected infants can present with some or all of the following signs and symptoms: constipation, poor feeding, ptosis (drooping eyelid), sluggish pupils, low muscle tone, difficulty sucking and swallowing, weak or altered cry, generalized weakness, respiratory difficulty, and possibly respiratory arrest.
Nara Organics Powdered Infant Formula was distributed nationally across Target retail stores, Target.com, and Nara.com between July 2025 and June 2026. Nara Infant Formula is not distributed outside of the USA.
Affected Product Details:
- Nara Organics Whole Milk Infant Formula, 700g, with UPC 860013251901
- Nara Organics Whole Milk Infant Formula, 400g, with UPC: 860013251918
All lots currently on the market are included in this voluntary recall, and the specific codes are as follows. The lot code can be found on the bottom of each can.
- 408125075E14F2
- 708125076E14F2
- 708125083E14F2
- 408125139E14F2
- 708125141E14F2
- 708125145E14F2
- 708125174E14F2
- 709125273E14F2
- 709125280E14F2
- 709125288E14F2
- 409125307E14F2
- 70926019ENNB
- 70926029ENNB
- 70926035ENNB
- 70926039ENNB
- 70926042ENNB
The Food and Drug Administration (FDA) and Center for Disease Control (CDC) contacted Nara Organics late Friday, June 12, 2026, and provided information about 3 cases of infant botulism in infants who CDC reported had consumed Nara formula. The 3 infants were hospitalized and treated with BabyBIG (Botulism Immune Globulin Intravenous) in California, Washington, and Pennsylvania. There are no reported deaths. The three specific product lots these infants were exposed to are: 709125280E14F2, 709125288E14F2, 708125174E14F2. To date, Nara infant formula has not tested positive for C. botulinum. However, Nara is voluntarily recalling all products currently in market.
Nara is taking aggressive action to ensure the safety of the babies and families who use the product as we work closely with the FDA, Centers for Disease Control and Prevention (CDC), and state partners to support their investigation into the root causes of these cases.
Customers should stop using the affected products immediately.